Developing Clinical Trials for Oncology Part 3: Growth Trends in Oncology Therapeutics
More than ever clinical trials are more complicated and more difficult to run. Denis Mir, Senior Manager of Clinical Operations in Oncology at Eisai Global Clinical Development, shares his thoughts on the key drivers and innovations supporting growth in oncology therapeutics and the challenges around the corner. For the full interview go to Developing Clinical Trials for Oncology - Denis Mir, Eisai Global Clinical Development
Have Your Say
Rate this feature and give us your feedback in the comments section below
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.